News Focus
News Focus
icon url

CryptoRain

10/18/12 4:51 PM

#26949 RE: KarenS #26945

Karen, I think the reference to "product formulation" was for the Macular tests and not referencing the drops...otherwise, very well said and keep up the great work!
icon url

HSmith

10/18/12 5:46 PM

#26955 RE: KarenS #26945

Karen, thanks for your post. I enjoy the fact that you are passionate about this stock. You selectively responded, so I would like to ask one question and make one request:

1) As I pointed out, on 5/15/12 Fuse stated that "distribution build out has begun" to the two hundred pharmacies in South Florida. That was FIVE MONTHS AG0! Let's eschew all the cool "corporate-speak" for a second. Fuse couldn't rent a truck, take a three day road trip and get Enerjel in a hundred of those pharmacies, easy? If I were running things, I would load up two hundred cases of Enerjel, roll out and not roll back in until Enerjel was in every one of those pharmacies. South Florida just ain't that big. Voila! "Distribution build out" over.

2) Please address points 1 through 5 made at the bottom of my post. Thanks.
icon url

malekabal42

10/18/12 9:00 PM

#26963 RE: KarenS #26945

Mgt released a statement saying that they would release the research results in early October. I don't think what was stated in the 8k qualifies. Unfortunately mgt has given the "bashers" a lot of ammo. As of now, this appears to be a typical pinksheet stock with hype and no revenues. The pps doesn't lie.